9d
Golf Digest on MSNHere’s the prize money payout for each golfer at the 2025 LPGA Founders CupYealimi Noh is finally in the winner's circle. After turning professional back in 2019, the 23-year-old from California shot ...
Takeda Pharmaceuticals has named Julie Kim as the first woman to lead the 244-year-old Japanese drugmaker, a rarity in senior management in the world’s fourth-largest economy. Kim, a US citizen ...
19d
Hosted on MSNHere's the prize money payout for each golfer at the 2025 LPGA Hilton Grand Vacation Tournament of ChampionsIt’s back to work for the LPGA as the tour begins its 75th anniversary season this week with the Hilton Grand Vacation Tournament of Champions. The 32-player, no-cut includes several of the top ...
Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.
Seri Pak has responded to the surprising news about the cancellation of the LPGA Tour event that bears her name, the World Golf Hall of Famer saying on social media she hopes the tournament can ...
“The LPGA will work with our committed title partner, Fir Hills, and LPGA legend Seri Pak as well as all other stakeholders to explore available options for rescheduling the event once this ...
Copyright 2025 The Associated Press. All Rights Reserved. Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] The LPGA canceled the Fir Hills Seri ...
Takeda has ended the manufacturing and supply of its gout drug Uloric in the US market as more patients turn to generic versions, the company … ...
Nelly Korda has one less title to defend in 2025. The Fir Hills Seri Pak Championship has been dropped from the LPGA’s spring schedule. The event, slated for March 20-23, was scheduled to be held at ...
The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the ...
Shares of Ascentage Pharma Group (AAPG) (OTCPK:AAPGV) (OTCPK:ASPHF), which is backed by Takeda (NYSE:TAK), were trading largely flat Friday following the company's $126M U.S. initial public offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results